Market Access Manager

Highly accomplished Pricing & Market Access expert with significant experience in launch pricing strategy, P&R plans, cross-indication strategy, value proposition development, global commercial opportunity and country-level implementation strategies

Deep knowledge of US (Medicare & Medicaid) and EU payer market systems, and conducting primary research with payers and other key stakeholders in these markets

Cross-indication P&MA assessment for an orphan drug for a rare nephrology disorder (US & EU)

Strategic market access options development, including a list of contracting options, for cystic fibrosis to drive commercial planning activities

C Global P&MA strategy for a novel gene therapy in hemophilia B (US, EU5, Brazil & Japan)

Cross-indication P&MA assessment for an orphan drug for a rare nephrology disorder (US & EU)

Strategic market access options development, including a menu of contracting options, for cystic fibrosis to drive commercial planning activities

Cross-indication P&MA assessment for an orphan drug for a rare nephrology disorder (US & EU)

Managed over 50 EU-based and global projects focused on pricing & market access strategy for tier 1 pharmaceutical companies

Developed expert knowledge of US and EU markets and experienced working with payers across US, CA, EU, LATAM and APAC